{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:49:00Z","timestamp":1791676140257,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12908-2","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:22:12Z","timestamp":1791667332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent trends and innovative strategies in the curative approach for \u03b2-thalassemia: a current prospect and future perspective"],"prefix":"10.1007","volume":"53","author":[{"given":"Faiza","family":"Usmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh Umair","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Ahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Saifullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"3","key":"12908_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/thalassrep13030018","volume":"13","author":"SS Khandker","year":"2023","unstructured":"Khandker SS, Jannat N, Sarkar D, Pranto AH, Hoque IA, Zaman J, Uddin MN, Suez E (2023) Association between glomerular filtration rate and \u03b2-thalassemia major: a systematic review and meta-analysis. Thalassemia Rep 13(3):195\u2013205","journal-title":"Thalassemia Rep"},{"issue":"3","key":"12908_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ajh.26798","volume":"98","author":"GL Forni","year":"2023","unstructured":"Forni GL, Gianesin B, Musallam KM, Longo F, Rosso R, Lisi R, Gamberini MR, Pinto VM, Graziadei G, Vitucci A (2023) Overall and complication-free survival in a large cohort of patients with \u03b2\u2010thalassemia major followed over 50 years. Am J Hematol 98(3):381\u2013387","journal-title":"Am J Hematol"},{"issue":"1","key":"12908_CR3","doi-asserted-by":"publisher","first-page":"13236","DOI":"10.1038\/s41598-023-35481-1","volume":"13","author":"S Ejaz","year":"2023","unstructured":"Ejaz S, Abdullah I, Usman M, Iqbal MA, Munawar S, Khan MI, Imtiaz N, Tahir H, Bari MI, Rasool T (2023) Mutational analysis of hemoglobin genes and functional characterization of detected variants, through in-silico analysis, in Pakistani beta-thalassemia major patients. Sci Rep 13(1):13236","journal-title":"Sci Rep"},{"issue":"3S","key":"12908_CR4","first-page":"5589","volume":"10","author":"M Ruk","year":"2023","unstructured":"Ruk M, Ujan JA, Unar K, Parveeen S, Amur A, Soomro AA, Lal S (2023) To Find Out the Prevalence of Thalassaemia in Sukkur Pakistan. J Surv Fisheries Sci 10(3S):5589\u20135598","journal-title":"J Surv Fisheries Sci"},{"issue":"02","key":"12908_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.53350\/pjmhs2023172456","volume":"17","author":"M Faizan","year":"2023","unstructured":"Faizan M, Rashid N, Hussain S, Khan A, Khan J, Zeb S, Ahmed SQ (2023) Prevalence and Clinical Features of Thalassemia Minor Cases. Pakistan J Med Health Sci 17(02):456\u2013456","journal-title":"Pakistan J Med Health Sci"},{"key":"12908_CR6","doi-asserted-by":"publisher","first-page":"148022","DOI":"10.1016\/j.gene.2023.148022","volume":"896","author":"E Rao","year":"2024","unstructured":"Rao E, Chandraker SK, Singh MM, Kumar R (2024) Global distribution of \u03b2-thalassemia mutations: An update. Gene 896:148022","journal-title":"Gene"},{"key":"12908_CR7","doi-asserted-by":"publisher","first-page":"1187681","DOI":"10.3389\/frhem.2023.1187681","volume":"2","author":"GL Forni","year":"2023","unstructured":"Forni GL, Grazzini G, Boudreaux J, Agostini V, Omert L (2023) Global burden and unmet needs in the treatment of transfusion-dependent \u03b2-thalassemia. Front Hematol 2:1187681","journal-title":"Front Hematol"},{"issue":"9","key":"12908_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/ajh.27006","volume":"98","author":"KM Musallam","year":"2023","unstructured":"Musallam KM, Lombard L, Kistler KD, Arregui M, Gilroy KS, Chamberlain C, Zagadailov E, Ruiz K, Taher AT (2023) Epidemiology of clinically significant forms of alpha-and beta\u2010thalassemia: A global map of evidence and gaps. Am J Hematol 98(9):1436\u20131451","journal-title":"Am J Hematol"},{"issue":"1","key":"12908_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/nyas.15097","volume":"1532","author":"M Angastiniotis","year":"2024","unstructured":"Angastiniotis M (2024) Beta thalassemia: Looking to the future, addressing unmet needs and challenges. Ann N Y Acad Sci 1532(1):63\u201372","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"12908_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11033-026-12103-3","volume":"53","author":"F Usmani","year":"2026","unstructured":"Usmani F, Yaseen MZ, Ali A, Nasir M (2026) Integrative analysis of single nucleotide polymorphism of PDE7B (rs2327669) with biopsychosocial and biochemical parameters in \u03b2-thalassemia major patients in Pakistani Cohort. Mol Biol Rep 53(1):945","journal-title":"Mol Biol Rep"},{"key":"12908_CR11","doi-asserted-by":"crossref","unstructured":"Tuo Y, Li Y, Li Y, Ma J, Yang X, Wu S, Jin J, He Z (2024) Global, regional, and national burden of thalassemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. EClinicalMedicine, 72","DOI":"10.1016\/j.eclinm.2024.102619"},{"key":"12908_CR12","doi-asserted-by":"publisher","first-page":"730873","DOI":"10.3389\/fphar.2021.730873","volume":"12","author":"P Rattananon","year":"2021","unstructured":"Rattananon P, Anurathapan U, Bhukhai K, Hongeng S (2021) The future of gene therapy for transfusion-dependent beta-thalassemia: The power of the lentiviral vector for genetically modified hematopoietic stem cells. Front Pharmacol 12:730873","journal-title":"Front Pharmacol"},{"issue":"10","key":"12908_CR13","doi-asserted-by":"publisher","first-page":"e1624","DOI":"10.1002\/hsr2.1624","volume":"6","author":"M Faranoush","year":"2023","unstructured":"Faranoush M, Faranoush P, Heydari I, Foroughi-Gilvaee MR, Azarkeivan A, Parsai Kia A, Sadighnia N, Elahinia A, Zandi A, Rezvany MR (2023) Complications in patients with transfusion dependent thalassemia: A descriptive cross\u2010sectional study. Health Sci Rep 6(10):e1624","journal-title":"Health Sci Rep"},{"issue":"13","key":"12908_CR14","first-page":"3479","volume":"118","author":"EA Rachmilewitz","year":"2011","unstructured":"Rachmilewitz EA, Giardina PJ (2011) How I treat thalassemia. Blood J Am Soc Hematol 118(13):3479\u20133488","journal-title":"Blood J Am Soc Hematol"},{"issue":"12","key":"12908_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/bmt.2016.243","volume":"51","author":"G Caocci","year":"2016","unstructured":"Caocci G, Vacca A, Piras E, Serreli V, Dessi C, Marcias M, Risso P, La Nasa G (2016) Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors. Bone Marrow Transplant 51(12):1640\u20131641","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"12908_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ajh.27102","volume":"99","author":"MW Garbowski","year":"2024","unstructured":"Garbowski MW, Ugidos M, Risue\u00f1o A, Shetty JK, Schwickart M, Hermine O, Porter JB, Thakurta A, Vodala S (2024) Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia. Am J Hematol 99(2):182\u2013192","journal-title":"Am J Hematol"},{"key":"12908_CR17","doi-asserted-by":"publisher","first-page":"102859","DOI":"10.1016\/j.bcmd.2024.102859","volume":"107","author":"KM Musallam","year":"2024","unstructured":"Musallam KM, Barella S, Origa R, Ferrero GB, Lisi R, Pasanisi A, Longo F, Gianesin B, Forni GL (2024) Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent \u03b2-thalassemia patients who remained on the same monotherapy over 10 years. Blood Cells Molecules Dis 107:102859","journal-title":"Blood Cells Molecules Dis"},{"issue":"3","key":"12908_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/v15030713","volume":"15","author":"EER Segura","year":"2023","unstructured":"Segura EER, Ayoub PG, Hart KL, Kohn DB (2023) Gene therapy for \u03b2-hemoglobinopathies: From discovery to clinical trials. Viruses 15(3):713","journal-title":"Viruses"},{"issue":"19","key":"12908_CR19","first-page":"3875","volume":"120","author":"C Li","year":"2012","unstructured":"Li C, Wu X, Feng X, He Y, Liu H, Pei F, Liao J, He L, Shi L, Li N (2012) A novel conditioning regimen improves outcomes in \u03b2-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation. Blood J Am Soc Hematol 120(19):3875\u20133881","journal-title":"Blood J Am Soc Hematol"},{"key":"12908_CR20","first-page":"154","volume":"9","author":"R Gelinas","year":"1992","unstructured":"Gelinas R, Frazier A, Harris E (1992) A normal level of beta-globin expression in erythroid cells after retroviral cells transfer. Bone Marrow Transplant 9:154\u2013157","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"12908_CR21","first-page":"3414","volume":"90","author":"H Raftopoulos","year":"1997","unstructured":"Raftopoulos H, Ward M, Leboulch P, Bank A (1997) Long-term transfer and expression of the human \u03b2-globin gene in a mouse transplant model. Blood J Am Soc Hematol 90(9):3414\u20133422","journal-title":"Blood J Am Soc Hematol"},{"issue":"15","key":"12908_CR22","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1089\/104303401753153947","volume":"12","author":"M Kumar","year":"2001","unstructured":"Kumar M, Keller B, Makalou N, Sutton RE (2001) Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 12(15):1893\u20131905","journal-title":"Hum Gene Ther"},{"issue":"1","key":"12908_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1566523214666141127095336","volume":"15","author":"O Negre","year":"2015","unstructured":"Negre O, Bartholomae C, Beuzard Y, Cavazzana M, Christiansen L, Courne C, Deichmann A, Denaro M, De Dreuzy E, Finer M (2015) Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of \u03b2-thalassemia and sickle cell disease. Curr Gene Ther 15(1):64\u201381","journal-title":"Curr Gene Ther"},{"issue":"7","key":"12908_CR24","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/mt.2011.20","volume":"19","author":"K Ronen","year":"2011","unstructured":"Ronen K, Negre O, Roth S, Colomb C, Malani N, Denaro M, Brady T, Fusil F, Gillet-Legrand B, Hehir K (2011) Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat \u03b2-thalassemia. Mol Ther 19(7):1273\u20131286","journal-title":"Mol Ther"},{"issue":"9","key":"12908_CR25","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1182\/bloodadvances.2019001330","volume":"4","author":"MM Hsieh","year":"2020","unstructured":"Hsieh MM, Bonner M, Pierciey Jr FJ, Uchida N, Rottman J, Demopoulos L, Schmidt M, Kanter J, Walters MC, Thompson AA (2020) Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease. Blood Adv 4(9):2058\u20132063","journal-title":"Blood Adv"},{"issue":"6","key":"12908_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-019-0020-9","volume":"18","author":"M Cavazzana","year":"2019","unstructured":"Cavazzana M, Bushman FD, Miccio A, Andr\u00e9-Schmutz I, Six E (2019) Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat Rev Drug Discovery 18(6):447\u2013462","journal-title":"Nat Rev Drug Discovery"},{"key":"12908_CR27","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1182\/blood-2019-126046","volume":"134","author":"AA Thompson","year":"2019","unstructured":"Thompson AA, Walters MC, Kwiatkowski JL, Hongeng S, Porter JB, Sauer MG, Thrasher AJ, Thuret I, Elliot H, Tao G (2019) Northstar-2: updated safety and efficacy analysis of lentiglobin gene therapy in patients with transfusion-dependent \u03b2-thalassemia and non-\u03b20\/\u03b20 genotypes. Blood 134:3543","journal-title":"Blood"},{"key":"12908_CR28","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1182\/blood-2019-125743","volume":"134","author":"AR Smith","year":"2019","unstructured":"Smith AR, Schiller GJ, Vercellotti GM, Kwiatkowski JL, Krishnamurti L, Esrick EB, Williams DA, Miller WP, Woolfson A, Walters MC (2019) Preliminary results of a phase 1\/2 clinical study of zinc finger nuclease-mediated editing of BCL11A in autologous hematopoietic stem cells for transfusion-dependent beta thalassemia. Blood 134:3544","journal-title":"Blood"},{"issue":"3","key":"12908_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul H, Altshuler D, Cappellini MD, Chen Y-S, Domm J, Eustace BK, Foell J, de la Fuente J, Grupp S, Handgretinger R (2021) CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N Engl J Med 384(3):252\u2013260","journal-title":"N Engl J Med"},{"issue":"4","key":"12908_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.molmed.2024.12.001","volume":"31","author":"G Hardouin","year":"2025","unstructured":"Hardouin G, Miccio A, Brusson M (2025) Gene therapy for \u03b2-thalassemia: current and future options. Trends Mol Med 31(4):344\u2013358","journal-title":"Trends Mol Med"},{"issue":"10","key":"12908_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S2352-4642(24)00167-6","volume":"8","author":"J Kahn","year":"2024","unstructured":"Kahn J, Brazauskas R, Bo-Subait S, Buchbinder D, Hamilton BK, Schoemans H, Abraham AA, Agrawal V, Auletta JJ, Badawy SM (2024) Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study. Lancet Child Adolesc Health 8(10):740\u2013750","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"12908_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbmt.2012.08.005","volume":"19","author":"C Galambrun","year":"2013","unstructured":"Galambrun C, Pondarr\u00e9 C, Bertrand Y, Loundou A, Bordigoni P, Frange P, Lutz P, Mialou V, Rubie H, Soci\u00e9 G (2013) French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions. Biol Blood Marrow Transplant 19(1):62\u201368","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"12908_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/bmt.2015.293","volume":"51","author":"D Baronciani","year":"2016","unstructured":"Baronciani D, Angelucci E, Potschger U, Gaziev J, Yesilipek A, Zecca M, Orofino M, Giardini C, Al-Ahmari A, Marktel S (2016) Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000\u20132010. Bone Marrow Transplant 51(4):536\u2013541","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"12908_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00277-008-0478-8","volume":"87","author":"K Ullah","year":"2008","unstructured":"Ullah K, Khan B, Raza S, Ahmed P, Satti TM, Butt T, Tariq WZ, Kamal MK (2008) Bone marrow transplant cure for \u03b2-thalassaemia major: initial experience from a developing country. Ann Hematol 87(8):655\u2013661","journal-title":"Ann Hematol"},{"issue":"5","key":"12908_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3324\/haematol.2013.099747","volume":"99","author":"E Angelucci","year":"2014","unstructured":"Angelucci E, Matthes-Martin S, Baronciani D, Bernaudin F, Bonanomi S, Cappellini MD, Dalle J-H, Di Bartolomeo P, de Heredia CD, Dickerhoff R (2014) Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica 99(5):811","journal-title":"Haematologica"},{"issue":"10","key":"12908_CR36","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bbmt.2009.06.013","volume":"15","author":"DM Jawdat","year":"2009","unstructured":"Jawdat DM, Saleh A, Sutton S, Al Anazi P, Shubaili H, Tamim A, H., Hajeer AH (2009) Chances of finding an HLA-matched sibling: The Saudi experience. Biol Blood Marrow Transplant 15(10):1342\u20131344","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"12908_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbmt.2020.01.002","volume":"26","author":"U Anurathapan","year":"2020","unstructured":"Anurathapan U, Hongeng S, Pakakasama S, Songdej D, Sirachainan N, Pongphitcha P, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K (2020) Hematopoietic stem cell transplantation for severe thalassemia patients from haploidentical donors using a novel conditioning regimen. Biol Blood Marrow Transplant 26(6):1106\u20131112","journal-title":"Biol Blood Marrow Transplant"},{"key":"12908_CR38","doi-asserted-by":"publisher","first-page":"102761","DOI":"10.1016\/j.bcmd.2023.102761","volume":"104","author":"A Nai","year":"2024","unstructured":"Nai A, Cordero-Sanchez C, Tanzi E, Pagani A, Silvestri L, Di Modica SM (2024) Cellular and animal models for the investigation of \u03b2-thalassemia. Blood Cells Molecules Dis 104:102761","journal-title":"Blood Cells Molecules Dis"},{"issue":"6","key":"12908_CR39","first-page":"568","volume":"134","author":"A Guerra","year":"2019","unstructured":"Guerra A, Oikonomidou PR, Sinha S, Zhang J, Lo Presti V, Hamilton CR, Breda L, Casu C, La P, Martins AC (2019) Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of \u03b2-thalassemia. Blood J Am Soc Hematol 134(6):568\u2013572","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"12908_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40265-019-01251-5","volume":"80","author":"A Markham","year":"2020","unstructured":"Markham A (2020) Luspatercept: first approval. Drugs 80(1):85\u201390","journal-title":"Drugs"},{"key":"12908_CR41","first-page":"S295280","volume":"295100","author":"S Corbacioglu","year":"2020","unstructured":"Corbacioglu S, Cappellini M, Chapin J, Chu-Osier N, Fernandez C, Foell J, Fuente J, Grupp S, Ho T, Kattamis A (2020) Initial safety and efficacy results with a single dose of autologous CRISPR-Cas9 modified CD34\u2009+\u2009hematopoietic stem and progenitor cells in transfusion-dependent \u03b2-thalassemia and sickle cell disease. EHA Libr 295100:S295280","journal-title":"EHA Libr"},{"issue":"6","key":"12908_CR42","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s00277-023-05457-2","volume":"103","author":"AM Alayoubi","year":"2024","unstructured":"Alayoubi AM, Khawaji ZY, Mohammed MA, Mercier FE (2024) CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia. Ann Hematol 103(6):1805\u20131817","journal-title":"Ann Hematol"},{"key":"12908_CR43","doi-asserted-by":"crossref","unstructured":"Zhang XH, Tee LY, Wang XG, Huang QS, Yang SH (2015) Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol therapy Nucleic acids, 4, e264","DOI":"10.1038\/mtna.2015.37"},{"issue":"1","key":"12908_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00438-022-01978-z","volume":"298","author":"A Khiabani","year":"2023","unstructured":"Khiabani A, Kohansal MH, Keshavarzi A, Shahraki H, Kooshesh M, Karimzade M, Gholizadeh Navashenaq J (2023) CRISPR\/Cas9, a promising approach for the treatment of \u03b2-thalassemia: A systematic review. Mol Genet Genomics 298(1):1\u201311","journal-title":"Mol Genet Genomics"},{"issue":"1","key":"12908_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.17582\/journal.pujz\/2023.38.1.65.73","volume":"38","author":"F Shafique","year":"2023","unstructured":"Shafique F, Ali S, ul Hassan M, Andleeb S (2023) Knowledge, Attitudes, and Perceptions Towards Beta-Thalassemia among Residents of Azad Kashmir, Pakistan. Punjab Univ J Zool 38(1):65\u201373","journal-title":"Punjab Univ J Zool"},{"key":"12908_CR46","unstructured":"Sa\u2019d Masood M, Hussain M, Rashid I (2023) Knowledge, Attitude, and Practices of Parents of Beta Thalassemia Patients. Medical Forum Monthly"},{"issue":"5","key":"12908_CR47","first-page":"13","volume":"5","author":"MA-T Mia","year":"2023","unstructured":"Mia MA-T, Islam MR, Sarker A, Shahriar EB, Hasan A, Ayon RA, Khalil MI, Hossain M, Hossain MI (2023) A Study on Knowledge, Attitudes, Practice and Awareness towards Pre-Marital Carrier Screening of Thalassemia among the University Students of Biological Faculty in Bangladesh: A Cross-Sectional Study. Eur J Med Health Sci 5(5):13\u201319","journal-title":"Eur J Med Health Sci"},{"issue":"5","key":"12908_CR48","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s12015-026-11132-6","volume":"22","author":"D Liang","year":"2026","unstructured":"Liang D, Schmidt-Wolf IGH, Pu J (2026) New gene therapy strategy for \u03b2-thalassemia. Stem Cell Reviews Rep 22(5):2235\u20132251","journal-title":"Stem Cell Reviews Rep"},{"issue":"1","key":"12908_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13104-024-06819-3","volume":"17","author":"MS Mousavi","year":"2024","unstructured":"Mousavi MS, Mohammadnezhad G, Yaghmaei F, Azarkeivan A, Esmaily H (2024) Awareness and practical evaluation of correct use of iron chelators; a study to track the ambiguities of thalassemia patients on their medications in Iran. BMC Res Notes 17(1):163","journal-title":"BMC Res Notes"},{"key":"12908_CR50","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.blre.2023.101138","volume":"63","author":"A El-Beshlawy","year":"2024","unstructured":"El-Beshlawy A, Dewedar H, Hindawi S, Alkindi S, Tantawy AA, Yassin MA, Taher AT (2024) Management of transfusion-dependent \u03b2-thalassemia (TDT): Expert insights and practical overview from the Middle East. Blood Rev 63:101138","journal-title":"Blood Rev"},{"issue":"6","key":"12908_CR51","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3390\/ijms25063400","volume":"25","author":"J Traeger-Synodinos","year":"2024","unstructured":"Traeger-Synodinos J, Vrettou C, Sofocleous C, Zurlo M, Finotti A, Gambari R (2024) Impact of \u03b1-Globin Gene Expression and \u03b1-Globin Modifiers on the Phenotype of \u03b2-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management. Int J Mol Sci 25(6):3400","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12908_CR52","doi-asserted-by":"publisher","first-page":"102911","DOI":"10.1016\/j.cpcardiol.2024.102911","volume":"50","author":"BA Ansharullah","year":"2025","unstructured":"Ansharullah BA, Sutanto H, Romadhon PZ (2025) Thalassemia and iron overload cardiomyopathy: Pathophysiological insights, clinical implications, and management strategies. Curr Probl Cardiol 50(1):102911","journal-title":"Curr Probl Cardiol"},{"key":"12908_CR53","doi-asserted-by":"crossref","unstructured":"Attia RA, Qureshi GSA, Safdar M, Raafat A, Janardhan G, Elshamy HAH, Malay J (2024) Gene Therapy: A Revolutionary Step in Treating Thalassemia","DOI":"10.20944\/preprints202406.0024.v1"},{"issue":"4","key":"12908_CR54","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/hematolrep16040064","volume":"16","author":"J Malay","year":"2024","unstructured":"Malay J, Salama RAA, Qureshi A, Ammar GS, Janardhan ARAA, Safdar G, M., Elshamy HAH (2024) Gene Therapy: A Revolutionary Step in Treating Thalassemia. Hematol Rep 16(4):656\u2013668","journal-title":"Hematol Rep"},{"issue":"7","key":"12908_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1358\/dot.2020.56.7.3159184","volume":"56","author":"F Pilo","year":"2020","unstructured":"Pilo F, Angelucci E (2020) Luspatercept to treat \u03b2-thalassemia. Drugs Today (Barcelona Spain: 1998) 56(7):447\u2013458","journal-title":"Drugs Today (Barcelona Spain: 1998)"},{"issue":"4","key":"12908_CR56","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.molmed.2024.12.001","volume":"31","author":"G Hardouin","year":"2025","unstructured":"Hardouin G, Miccio A, Brusson M (2025) Gene therapy for \u03b2-thalassemia: current and future options. Trends Mol Med 31(4):344\u2013358","journal-title":"Trends Mol Med"},{"key":"12908_CR57","doi-asserted-by":"publisher","first-page":"263300402614330","DOI":"10.1177\/26330040261433028","volume":"7","author":"AN Cheng","year":"2026","unstructured":"Cheng AN, Kwiatkowski JL (2026) Current therapeutic landscape of \u03b2-thalassemia: focus on gene therapy. Therapeutic Adv Rare Disease 7:26330040261433028","journal-title":"Therapeutic Adv Rare Disease"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12908-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12908-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12908-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:05:57Z","timestamp":1791673557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12908-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12908"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12908-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"1 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Ethical approval was not required for this study because it is a review article based exclusively on previously published literature.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"1703"}}